Innate immune signaling and stress response
- Institution
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN
- Principal investigator
- Thirumala-Devi Kanneganti
- Funding
- $539K
- Duration
- 2016–2026
Moonbase score
Still being scored
Abstract
ABSTRACT Membraneless compartments play a vital role in maintaining cellular and organismal homeostasis by modulating cell survival and cell death. Stress granules, and inflammasome-induced specks are membraneless compartments that provide contrasting cell fate choices to the cells – survival or pyroptosis (programmed cell death) during physiological or virus induced cellular stress. NLRP3, a global sensor of pathogen–associated molecular patterns (PAMPs) and danger–associated molecular patterns (DAMPs), senses cellular perturbations in the cytosol to trigger the assembly of a large caspase-1-activating protein complex termed the NLRP3 inflammasome. Autoproteolytic maturation of caspase-1 due to NLRP3 inflammasome activation leads to pyroptosis, and maturation of pro-inflammatory cytokines interleukin (IL)- 1β and IL-18. Despite the ability of NLRP3 to respond to diverse cues of cellular or virus induced stress, mechanisms controlling the cross-talk between inflammasomes and stress granules remain elusive. In our quest to study this cross-talk, we have identified DDX3X, a stress granule component, as an upstream regulator of NLRP3 inflammasome to canonical and viral triggers. In this R01 renewal, we propose to identify the molecular and cellular mechanisms of DDX3X-mediated NLPR3 inflammasome activation and its modulation by stress signals during inflammation and viral infections. Understanding the cross-talk between cellular stress response molecules and innate immune signaling will lead to novel therapeutic targets for inflammatory and infectious diseases.
LOADING MOONBASE SCORE
Questions for ST. JUDE CHILDREN'S RESEARCH HOSPITAL
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · ST. Jude Children'S Research HospitalNot yet scored
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
Thirumala-Devi Kanneganti · $764K · 2021–2026
- NIH · ST. Jude Children'S Research HospitalNot yet scored
Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancer
Thirumala-Devi Kanneganti · $1.1M · 2020–2027
- NIH · ST. Jude Children'S Research HospitalNot yet scored
Inflammatory Caspases in Innate Immunity and Inflammation
Thirumala-Devi Kanneganti · $455K · 2012–2027